Cover Page
Cover Page | 9 Months Ended |
Sep. 30, 2023 shares | |
Cover [Abstract] | |
Document Type | 10-Q |
Document Quarterly Report | true |
Document Period End Date | Sep. 30, 2023 |
Document Transition Report | false |
Entity File Number | 001-13908 |
Entity Registrant Name | Invesco Ltd. |
Entity Incorporation, State or Country Code | D0 |
Entity Tax Identification Number | 98-0557567 |
Entity Address, Address Line One | 1331 Spring Street, |
Entity Address, Address Line Two | Suite 2500, |
Entity Address, City or Town | Atlanta, |
Entity Address, State or Province | GA |
Entity Address, Postal Zip Code | 30309 |
City Area Code | 404 |
Local Phone Number | 892-0896 |
Title of 12(b) Security | Common stock, $0.20 par value |
Trading Symbol | IVZ |
Security Exchange Name | NYSE |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Small Business | false |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 449,554,399 |
Entity Central Index Key | 0000914208 |
Current Fiscal Year End Date | --12-31 |
Document Fiscal Year Focus | 2023 |
Document Fiscal Period Focus | Q3 |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
ASSETS | ||
Cash and cash equivalents | $ 1,241.5 | $ 1,234.7 |
Accounts receivable | 645.4 | 801.8 |
Investments | 932.6 | 996.6 |
Cash and cash equivalents of CIP | 313.6 | 199.4 |
Accounts receivable and other assets of CIP | 257.9 | 203.7 |
Investments of CIP | 8,612.9 | 8,531.4 |
Assets held for policyholders | 408.4 | |
Other assets | 764.1 | 860.5 |
Property, equipment and software, net | 586.2 | 561.1 |
Intangible assets, net | 7,100.1 | 7,141.2 |
Goodwill | 8,568.8 | 8,557.7 |
Total assets | 29,431.5 | 29,756.8 |
LIABILITIES | ||
Accrued compensation and benefits | 733.6 | 860.8 |
Accounts payable and accrued expenses | 1,291.6 | 1,314.8 |
Debt of CIP | 6,981.5 | 6,590.4 |
Other liabilities of CIP | 322.3 | 329.6 |
Policyholder payables | 408.4 | 668.7 |
Debt | 1,489.1 | 1,487.6 |
Deferred tax liabilities, net | 1,613.3 | 1,662.7 |
Total liabilities | 12,839.8 | 12,914.6 |
Commitments and contingencies (See Note 10) | ||
TEMPORARY EQUITY | ||
Redeemable noncontrolling interests in consolidated entities | 754.1 | 998.7 |
Equity attributable to Invesco Ltd.: | ||
Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of September 30, 2023 and December 31, 2022) | 4,010.5 | 4,010.5 |
Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of September 30, 2023 and December 31, 2022) | 113.2 | 113.2 |
Additional paid-in-capital | 7,442.8 | 7,554.9 |
Treasury shares | (3,010.8) | (3,040.9) |
Retained earnings | 7,658.8 | 7,518.3 |
Accumulated other comprehensive income/(loss), net of tax | (960.6) | (942.4) |
Total equity attributable to Invesco Ltd. | 15,253.9 | 15,213.6 |
Equity attributable to nonredeemable noncontrolling interests in consolidated entities | 583.7 | 629.9 |
Total permanent equity | 15,837.6 | 15,843.5 |
Total liabilities, temporary and permanent equity | $ 29,431.5 | $ 29,756.8 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock par value (in USD per share) | $ 0.20 | $ 0.20 |
Liquidation preference per share (in USD per share) | $ 1,000 | $ 1,000 |
Preferred stock authorized (in shares) | 4 | 4 |
Preferred shares issued (in shares) | 4 | 4 |
Preferred shares outstanding (in shares) | 4 | 4 |
Common stock par value (in USD per share) | $ 0.20 | $ 0.20 |
Common stock authorized (in shares) | 1,050 | 1,050 |
Common stock issued (in shares) | 566.1 | 566.1 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Operating revenues: | ||||
Total operating revenues | $ 1,442 | $ 1,445.7 | $ 4,303 | $ 4,605.5 |
Operating expenses: | ||||
Third-party distribution, service and advisory | 448.2 | 451.3 | 1,365.8 | 1,438.9 |
Employee compensation | 478.5 | 420.8 | 1,417 | 1,260.9 |
Marketing | 23.7 | 27.6 | 77.7 | 83.1 |
Property, office and technology | 135.4 | 133.2 | 406.9 | 400.2 |
General and administrative | 117.2 | 48.7 | 314.5 | 270.6 |
Transaction, integration and restructuring | 0 | (0.6) | 41.6 | 34.8 |
Amortization of intangibles | 11.3 | 14.5 | 38.5 | 44.4 |
Total operating expenses | 1,214.3 | 1,095.5 | 3,662 | 3,532.9 |
Operating income | 227.7 | 350.2 | 641 | 1,072.6 |
Other income/(expense): | ||||
Equity in earnings of unconsolidated affiliates | 16.9 | 20.2 | 62.2 | 78.3 |
Interest and dividend income | 10.8 | 3.3 | 26.5 | 6.6 |
Interest expense | (17.3) | (18.6) | (53.7) | (67.6) |
Other gains/(losses), net | (23.3) | (34.6) | 25 | (170.1) |
Other income/(expense) of CIP, net | 15.2 | (65.4) | (5.4) | (62.5) |
Income before income taxes | 230 | 255.1 | 695.6 | 857.3 |
Income tax provision | (61.3) | (86.8) | (196.7) | (232.6) |
Net income | 168.7 | 168.3 | 498.9 | 624.7 |
Net (income)/loss attributable to noncontrolling interests in consolidated entities | 21.9 | 68.3 | 87.3 | 49 |
Dividends declared on preferred shares | (59.2) | (59.2) | (177.6) | (177.6) |
Net income attributable to Invesco Ltd. | $ 131.4 | $ 177.4 | $ 408.6 | $ 496.1 |
Earnings per common share: | ||||
Basic (in USD per share) | $ 0.29 | $ 0.39 | $ 0.90 | $ 1.08 |
Diluted (in USD per share) | $ 0.29 | $ 0.39 | $ 0.89 | $ 1.08 |
Investment management fees | ||||
Operating revenues: | ||||
Total operating revenues | $ 1,041.3 | $ 1,057.3 | $ 3,102.7 | $ 3,351.3 |
Service and distribution fees | ||||
Operating revenues: | ||||
Total operating revenues | 353.5 | 340.2 | 1,030 | 1,073 |
Performance fees | ||||
Operating revenues: | ||||
Total operating revenues | 2 | 3 | 27.2 | 13.2 |
Other | ||||
Operating revenues: | ||||
Total operating revenues | $ 45.2 | $ 45.2 | $ 143.1 | $ 168 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 168.7 | $ 168.3 | $ 498.9 | $ 624.7 |
Other comprehensive income/(loss), net of tax: | ||||
Currency translation differences on investments in foreign subsidiaries | (143) | (330.1) | (24.1) | (690.2) |
Other comprehensive income/(loss), net of tax | 0.7 | 0.2 | 5.9 | 0.7 |
Other comprehensive income/(loss) | (142.3) | (329.9) | (18.2) | (689.5) |
Total comprehensive income/(loss) | 26.4 | (161.6) | 480.7 | (64.8) |
Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities | 21.9 | 68.3 | 87.3 | 49 |
Dividends declared on preferred shares | (59.2) | (59.2) | (177.6) | (177.6) |
Comprehensive income/(loss) attributable to Invesco Ltd. | $ (10.9) | $ (152.5) | $ 390.4 | $ (193.4) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Operating activities: | ||
Net income | $ 498.9 | $ 624.7 |
Adjustments to reconcile net income to net cash provided by/(used in) operating activities: | ||
Amortization and depreciation | 136.4 | 146.7 |
Common share-based compensation expense | 93.7 | 83.1 |
Other (gains)/losses, net | (23) | 170.1 |
Other (gains)/losses of CIP, net | 167.8 | 173.2 |
Equity in earnings of unconsolidated affiliates | (62.2) | (78.3) |
Distributions from equity method investees | 67.8 | 64.3 |
Changes in operating assets and liabilities: | ||
(Purchase)/sale of investments by CIP, net | (377.7) | (397.2) |
(Purchase)/sale of investments, net | 17.2 | (20.5) |
(Increase)/decrease in receivables | 503.5 | 721.9 |
Increase/(decrease) in payables | (435.9) | (1,248.3) |
Net cash provided by/(used in) operating activities | 586.5 | 239.7 |
Investing activities: | ||
Purchase of property, equipment and software | (124) | (119.8) |
Purchase of investments by CIP | (1,982.1) | (2,335.7) |
Sale of investments by CIP | 2,149.7 | 2,274.5 |
Purchase of investments | (85.1) | (173.5) |
Sale of investments | 50.8 | 73.4 |
Capital distribution from equity method investees | 18.5 | 38.7 |
Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP | (10.5) | 4.4 |
Net cash provided by/(used in) investing activities | 17.3 | (238) |
Financing activities: | ||
Purchases of treasury shares | (183.1) | (240.1) |
Dividends paid - preferred | (177.6) | (177.6) |
Dividends paid - common | (267.7) | (249.1) |
Third-party capital invested into CIP | 120.5 | 608.8 |
Third-party capital distributed by CIP | (196.2) | (191.2) |
Borrowings of debt of CIP | 545.1 | 54.3 |
Repayments of debt of CIP | (316.1) | (3.9) |
Repayments of senior notes | 0 | (600) |
Net cash provided by/(used in) financing activities | (475.1) | (798.8) |
Increase/(decrease) in cash and cash equivalents | 128.7 | (797.1) |
Supplemental Cash Flow Information [Abstract] | ||
Foreign exchange movement on cash and cash equivalents | (7.3) | (114) |
Foreign exchange movement on cash and cash equivalents of CIP | (0.4) | (10) |
Cash and cash equivalents, beginning of period | 1,434.1 | 2,147.1 |
Cash and cash equivalents, end of period | 1,555.1 | 1,226 |
Cash and cash equivalents | 1,241.5 | 1,023.6 |
Cash and cash equivalents of CIP | 313.6 | 202.4 |
Total cash and cash equivalents per condensed consolidated statement of cash flows | $ 1,555.1 | $ 1,226 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Millions | Total | Preferred Shares | Common Shares | Additional Paid-in-Capital | Treasury Shares | Retained Earnings | Accumulated Other Comprehensive Income/(Loss) | Total Equity Attributable to Invesco Ltd. | Nonredeemable Noncontrolling Interests in Consolidated Entities |
Beginning balance at Dec. 31, 2021 | $ 16,168 | $ 4,010.5 | $ 113.2 | $ 7,688 | $ (3,043.6) | $ 7,169.2 | $ (441.5) | $ 15,495.8 | $ 672.2 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 666.8 | 673.7 | 673.7 | (6.9) | |||||
Other comprehensive income/(loss) | (689.5) | (689.5) | (689.5) | ||||||
Change in noncontrolling interests in consolidated entities, net | (55.9) | (55.9) | |||||||
Dividends declared - preferred | (177.6) | (177.6) | (177.6) | ||||||
Dividends declared - common | (249.1) | (249.1) | (249.1) | ||||||
Common share-based compensation | 83.1 | 83.1 | 83.1 | ||||||
Vested common shares | (219.3) | 219.3 | |||||||
Other common share awards | 7.4 | (4.8) | 12.2 | 7.4 | |||||
Purchase of common shares | (240.1) | (240.1) | (240.1) | ||||||
Ending balance at Sep. 30, 2022 | 15,513.1 | 4,010.5 | 113.2 | 7,547 | (3,052.2) | 7,416.2 | (1,131) | 14,903.7 | 609.4 |
Beginning balance at Dec. 31, 2021 | 510.8 | ||||||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||||||
Net income | (42.1) | ||||||||
Change in noncontrolling interests in consolidated entities, net | 521.7 | ||||||||
Ending balance at Sep. 30, 2022 | 990.4 | ||||||||
Beginning balance at Jun. 30, 2022 | 15,794.8 | 4,010.5 | 113.2 | 7,563.2 | (3,095.3) | 7,323.2 | (801.1) | 15,113.7 | 681.1 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 177 | 236.6 | 236.6 | (59.6) | |||||
Other comprehensive income/(loss) | (329.9) | (329.9) | (329.9) | ||||||
Change in noncontrolling interests in consolidated entities, net | (12.1) | (12.1) | |||||||
Dividends declared - preferred | (59.2) | (59.2) | (59.2) | ||||||
Dividends declared - common | (84.4) | (84.4) | (84.4) | ||||||
Common share-based compensation | 26 | 26 | 26 | ||||||
Vested common shares | (36.6) | 36.6 | |||||||
Other common share awards | 6.6 | (5.6) | 12.2 | 6.6 | |||||
Purchase of common shares | (5.7) | (5.7) | (5.7) | ||||||
Ending balance at Sep. 30, 2022 | 15,513.1 | 4,010.5 | 113.2 | 7,547 | (3,052.2) | 7,416.2 | (1,131) | 14,903.7 | 609.4 |
Beginning balance at Jun. 30, 2022 | 892.8 | ||||||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||||||
Net income | (8.7) | ||||||||
Change in noncontrolling interests in consolidated entities, net | 106.3 | ||||||||
Ending balance at Sep. 30, 2022 | 990.4 | ||||||||
Beginning balance at Dec. 31, 2022 | 15,843.5 | 4,010.5 | 113.2 | 7,554.9 | (3,040.9) | 7,518.3 | (942.4) | 15,213.6 | 629.9 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 551.1 | 586.2 | 586.2 | (35.1) | |||||
Other comprehensive income/(loss) | (18.2) | (18.2) | (18.2) | ||||||
Change in noncontrolling interests in consolidated entities, net | (11.5) | (0.4) | (0.4) | (11.1) | |||||
Dividends declared - preferred | (177.6) | (177.6) | (177.6) | ||||||
Dividends declared - common | (267.7) | (267.7) | (267.7) | ||||||
Common share-based compensation | 93.7 | 93.7 | 93.7 | ||||||
Vested common shares | (196.6) | 196.6 | |||||||
Other common share awards | 7.4 | (9.2) | 16.6 | 7.4 | |||||
Purchase of common shares | (183.1) | (183.1) | (183.1) | ||||||
Ending balance at Sep. 30, 2023 | 15,837.6 | 4,010.5 | 113.2 | 7,442.8 | (3,010.8) | 7,658.8 | (960.6) | 15,253.9 | 583.7 |
Beginning balance at Dec. 31, 2022 | 998.7 | ||||||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||||||
Net income | (52.2) | ||||||||
Change in noncontrolling interests in consolidated entities, net | (192.4) | ||||||||
Ending balance at Sep. 30, 2023 | 754.1 | ||||||||
Beginning balance at Jun. 30, 2023 | 15,866.7 | 4,010.5 | 113.2 | 7,433 | (3,027.4) | 7,617.9 | (818.3) | 15,328.9 | 537.8 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net income | 194.2 | 190.6 | 190.6 | 3.6 | |||||
Other comprehensive income/(loss) | (142.3) | (142.3) | (142.3) | ||||||
Change in noncontrolling interests in consolidated entities, net | 41.9 | (0.4) | (0.4) | 42.3 | |||||
Dividends declared - preferred | (59.2) | (59.2) | (59.2) | ||||||
Dividends declared - common | (90.1) | (90.1) | (90.1) | ||||||
Common share-based compensation | 23.9 | 23.9 | 23.9 | ||||||
Vested common shares | (8.3) | 8.3 | |||||||
Other common share awards | 6.4 | (5.8) | 12.2 | 6.4 | |||||
Purchase of common shares | (3.9) | (3.9) | (3.9) | ||||||
Ending balance at Sep. 30, 2023 | 15,837.6 | $ 4,010.5 | $ 113.2 | $ 7,442.8 | $ (3,010.8) | $ 7,658.8 | $ (960.6) | $ 15,253.9 | $ 583.7 |
Beginning balance at Jun. 30, 2023 | 841.9 | ||||||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||||||
Net income | (25.5) | ||||||||
Change in noncontrolling interests in consolidated entities, net | (62.3) | ||||||||
Ending balance at Sep. 30, 2023 | $ 754.1 |
Condensed Consolidated Statem_5
Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Stockholders' Equity [Abstract] | ||||
Preferred stock dividend declared (in USD per share) | $ 14.75 | $ 14.75 | $ 44.25 | $ 44.25 |
Common stock dividends declared per share (in USD per share) | $ 0.20 | $ 0.1875 | $ 0.5875 | $ 0.5450 |
ACCOUNTING POLICIES
ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
ACCOUNTING POLICIES | ACCOUNTING POLICIES Corporate Information Invesco Ltd. (the Parent) and its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of investment management capabilities. The company operates globally and its sole business is investment management. Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2022 (annual report or Form 10-K) are not required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these disclosures. Therefore, this Report should be read in conjunction with the company’s annual report. Basis of Accounting and Consolidation The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. Accounting Pronouncements Recently Adopted None. Pending Accounting Pronouncements None. |
FAIR VALUE OF ASSETS AND LIABIL
FAIR VALUE OF ASSETS AND LIABILITIES | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE OF ASSETS AND LIABILITIES | FAIR VALUE OF ASSETS AND LIABILITIES The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products". See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. September 30, 2023 December 31, 2022 (in millions) Fair Value Fair Value Cash and cash equivalents $ 1,241.5 $ 1,234.7 Equity investments 271.0 325.0 Foreign time deposits (1) — 25.7 Assets held for policyholders 408.4 668.7 Policyholder payables (1) (408.4) (668.7) Total return swaps related to deferred compensation plans (10.1) (1.6) ____________ (1) These financial instruments are not measured at fair value on a recurring basis. Foreign time deposits are measured at cost plus accrued interest, which approximates fair value, and are accordingly classified as Level 2 securities. Policyholder payables are indexed to the value of the assets held for policyholders and changes in fair value are recorded and offset to zero in other operating revenues . The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022, respectively: As of September 30, 2023 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds (1) $ 711.3 $ 711.3 $ — $ — Investments: (2) Equity investments: Seed capital 90.0 90.0 — — Investments related to deferred compensation plans 179.6 179.6 — — Other equity securities 1.4 1.4 — — Assets held for policyholders (3) 408.4 408.4 — — Total $ 1,390.7 $ 1,390.7 $ — $ — Liabilities: Total return swaps related to deferred compensation plans (10.1) — (10.1) — Contingent consideration liability $ (1.3) $ — $ — $ (1.3) Total $ (11.4) $ — $ (10.1) $ (1.3) As of December 31, 2022 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds (1) $ 760.8 $ 760.8 $ — $ — Investments (2) : Equity investments: Seed capital 177.9 177.9 — — Investments related to deferred compensation plans 146.1 146.1 — — Other equity securities 1.0 1.0 — — Assets held for policyholders (3) 668.7 668.7 — — Total $ 1,754.5 $ 1,754.5 $ — $ — Liabilities: Total return swaps related to deferred compensation plans $ (1.6) $ — $ (1.6) $ — Contingent consideration liability (1.3) — — (1.3) Total $ (2.9) $ — $ (1.6) $ (1.3) ____________ ( 1) The balance primarily represents cash held in affiliated money market funds. (2) Equity method and other investments of $637.0 million and $24.6 million, res pectively, are excluded from this table (December 31, 2022: $621.2 million and $24.7 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards. (3) The majority of a ssets held for policyholders are held in affiliated funds. Total Return Swaps (TRS) In addition to holding equity investments, the company has TRS to hedge economically cer tain deferred compensation liabilities. The notional value of the TRS at September 30, 2023 was $366.2 million, a nd the fair value of the TRS was a liability of $10.1 million (December 31, 2022 notional value was $326.6 million and the fair value was a liability of $1.6 million). The company’s net collateral paid balance related to the TRS was $11.9 million at September 30, 2023 (December 31, 2022: $0.0 million). During the three months ended September 30, 2023, market valuation losses related to the TRS of $16.6 million w ere recognized in Other gains/(losses), net (three months ended September 30, 2022: $19.8 million net loss). During the nine months ended September 30, 2023, market valuation gains related to the TRS of $3.8 million w ere recognized in Other gains/(losses), net (nine months ended September 30, 2022: $91.9 million net loss). |
INVESTMENTS
INVESTMENTS | 9 Months Ended |
Sep. 30, 2023 | |
Investments [Abstract] | |
INVESTMENTS | INVESTMENTS The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 11, "Consolidated Investment Products". (in millions) September 30, 2023 December 31, 2022 Equity investments: Seed capital $ 90.0 $ 177.9 Investments related to deferred compensation plans 179.6 146.1 Other equity securities 1.4 1.0 Equity method investments 637.0 621.2 Foreign time deposits — 25.7 Other 24.6 24.7 Total investments (1) $ 932.6 $ 996.6 ____________ (1) The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees. Equity investments The unrealized gains and losses for the three and nine months ended September 30, 2023 that relate to equity investments still held at September 30, 2023, were a $10.8 million net loss and $13.2 million net gain (three and nine months ended September 30, 2022: $14.4 million net loss and $84.1 million net loss ). |
DEBT
DEBT | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
DEBT | DEBT The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products". September 30, 2023 December 31, 2022 (in millions) Carrying Value (2) Fair Value Carrying Value (2) Fair Value $2.0 billion floating rate credit facility expiring April 26, 2028 $ — $ — $ — $ — Unsecured Senior Notes: (1) $600 million 4.000% - due January 30, 2024 599.6 596.0 598.8 591.5 $500 million 3.750% - due January 15, 2026 498.4 479.2 497.9 486.4 $400 million 5.375% - due November 30, 2043 391.1 358.9 390.9 397.3 Debt $ 1,489.1 $ 1,434.1 $ 1,487.6 $ 1,475.2 ____________ (1) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures. (2) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts. |
SHARE CAPITAL
SHARE CAPITAL | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
SHARE CAPITAL | SHARE CAPITAL The number of preferred shares issued and outstanding is represented in the table below: As of (in millions) September 30, 2023 December 31, 2022 Preferred shares issued (1) 4.0 4.0 Preferred shares outstanding (1) 4.0 4.0 __________ (1) Preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024. The number o f common shares and common share equivalents issued are represented in the table below: As of (in millions) September 30, 2023 December 31, 2022 Common shares issued 566.1 566.1 Less: Treasury shares for which dividend and voting rights do not apply (116.5) (111.3) Common shares outstanding 449.6 454.8 |
OTHER COMPREHENSIVE INCOME_(LOS
OTHER COMPREHENSIVE INCOME/(LOSS) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
OTHER COMPREHENSIVE INCOME/(LOSS) | OTHER COMPREHENSIVE INCOME/(LOSS) The components of accumulated other comprehensive income/(loss) were as follows: Three months ended September 30, 2023 Three months ended September 30, 2022 (in millions) Foreign currency translation Employee benefit plans Total Foreign currency translation Employee benefit plans Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries $ (143.0) $ — $ (143.0) $ (330.1) $ — $ (330.1) Other comprehensive income/(loss), net — 0.7 0.7 — 0.2 0.2 Other comprehensive income/(loss), net of tax (143.0) 0.7 (142.3) (330.1) 0.2 (329.9) Beginning balance (696.1) (122.2) (818.3) (712.0) (89.1) (801.1) Other comprehensive income/(loss), net of tax (143.0) 0.7 (142.3) (330.1) 0.2 (329.9) Ending balance $ (839.1) $ (121.5) $ (960.6) $ (1,042.1) $ (88.9) $ (1,131.0) Nine months ended September 30, 2023 Nine months ended September 30, 2022 (in millions) Foreign currency translation Employee benefit plans Total Foreign currency translation Employee benefit plans Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries $ (24.1) $ — $ (24.1) $ (690.2) $ — $ (690.2) Other comprehensive income/(loss), net — 5.9 5.9 — 0.7 0.7 Other comprehensive income/(loss), net of tax (24.1) 5.9 (18.2) (690.2) 0.7 (689.5) Beginning balance (815.0) (127.4) (942.4) (351.9) (89.6) (441.5) Other comprehensive income/(loss), net of tax (24.1) 5.9 (18.2) (690.2) 0.7 (689.5) Ending balance $ (839.1) $ (121.5) $ (960.6) $ (1,042.1) $ (88.9) $ (1,131.0) |
REVENUE
REVENUE | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
REVENUE | REVENUE The geographic disaggregation of revenue for the three and nine months ended September 30, 2023 and 2022 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda. Three months ended September 30, (in millions) 2023 2022 Americas $ 1,107.3 $ 1,125.1 Asia-Pacific (APAC) 64.6 63.2 Europe, Middle East and Africa (EMEA) 270.1 257.4 Total operating revenues $ 1,442.0 $ 1,445.7 Nine months ended September 30, (in millions) 2023 2022 Americas $ 3,298.8 $ 3,553.2 Asia-Pacific (APAC) $ 198.2 $ 218.7 Europe, Middle East and Africa (EMEA) $ 806.0 $ 833.6 Total operating revenues $ 4,303.0 $ 4,605.5 |
COMMON SHARE-BASED COMPENSATION
COMMON SHARE-BASED COMPENSATION | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
COMMON SHARE-BASED COMPENSATION | COMMON SHARE-BASED COMPENSATION The company recognized total compensation expense of $93.7 million and $83.1 million related to equity-settled common share-based payment transactions in the nine months ended September 30, 2023 and 2022, respectively. Movements on employee common share awards during the periods ended September 30 are detailed below: Nine months ended September 30, 2023 Nine months ended September 30, 2022 (in millions of common shares, except fair values) Time- Vested Performance- Vested Weighted Average Grant Date Fair Value Time- Vested Performance- Vested Unvested at the beginning of period 10.3 2.1 $ 19.03 13.5 1.9 Granted during the period 5.2 0.7 17.64 3.6 1.0 Forfeited during the period (0.2) (0.2) 16.49 (0.3) (0.1) Vested and distributed during the period (5.0) (0.5) 18.02 (6.2) (0.4) Unvested at the end of the period 10.3 2.1 $ 18.90 10.6 2.4 The total fair value of common shares that vested during the nine months ended September 30, 2023 was $96.3 million (nine months ended September 30, 2022: $131.7 million). The weighted average grant date fair value of the U.S. dollar share awards that were granted during the nine months ended September 30, 2023 was $17.64 (nine months ended September 30, 2022: $21.23). |
EARNINGS PER COMMON SHARE
EARNINGS PER COMMON SHARE | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
EARNINGS PER COMMON SHARE | EARNINGS PER COMMON SHARE The calculation of earnings per common share (EPS) is as follows: Three months ended September 30, Nine months ended September 30, (in millions, except per share data) 2023 2022 2023 2022 Net income attributable to Invesco Ltd. $ 131.4 $ 177.4 $ 408.6 $ 496.1 Invesco Ltd: Weighted average common shares outstanding - basic 451.7 457.0 455.9 457.7 Dilutive effect of non-participating common share-based awards 1.4 2.5 1.3 2.3 Weighted average common shares outstanding - diluted 453.1 459.5 457.2 460.0 Earnings per common share: -basic $ 0.29 $ 0.39 $ 0.90 $ 1.08 -diluted $ 0.29 $ 0.39 $ 0.89 $ 1.08 See Note 8, "Common Share-Based Compensation," for a summary of common share awards outstanding under the company’s common share-based payment programs. These programs could result in the issuance of common shares that would affect the measurement of basic and diluted EPS. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES Commitments and contingencies may arise in the ordinary course of business. The company has committed to co-invest in certain investment products, which may be called in future periods. At September 30, 2023, the company’s undrawn co-invest capital commitments were $659.0 million (December 31, 2022: $336.1 million). The increase in capital commitments is driven by our continued support for private markets’ capabilities. Certain of our managed investment products have entered into revolving credit facilities with financial institutions. Pursuant to these arrangements, the company provided equity commitments and guarantees to certain of these investment products that are temporary in nature. The revolving credit facilities look first to the respective investment products for repayment and servicing. The company’s equity commitment or guarantee would only be called in the event a particular investment product is unable to meet its obligation. The company believes the likelihood of being required to fund its equity commitments or guarantees under these arrangements to be remote. To date, the company has not been required to fund any equity commitments or guarantees under these arrangements. The maximum amount of future payments under the commitments is $274 million and under the guarantees is $30.0 million. The fair value of the guarantee liability is not significant to the consolidated financial statements. The company and some of its subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote. Legal Contingencies The company is from time to time involved in pending or threatened litigation relating to claims arising in the ordinary course of its business. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit or claim will have on the company. There are many reasons that the company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages (or merely threatened); the damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other parties who may share in any ultimate liability. |
CONSOLIDATED INVESTMENT PRODUCT
CONSOLIDATED INVESTMENT PRODUCTS | 9 Months Ended |
Sep. 30, 2023 | |
Consolidated Investment Products [Abstract] | |
CONSOLIDATED INVESTMENT PRODUCTS | CONSOLIDATED INVESTMENT PRODUCTS The balances related to CIP are identified on the Consolidated Balance Sheets. At September 30, 2023, the company’s net investment in and net receivables from CIP were $543.6 million (December 31, 2022: $386.6 million). The consolidation of CIP had no impact on net income attributable to the company during the three months and nine months ended September 30, 2023. The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of September 30, 2023 and December 31, 2022: As of September 30, 2023 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Investments Measured at NAV as a practical expedient Assets: Bank loans $ 6,679.2 $ — $ 6,127.7 $ 551.5 $ — Bonds 683.2 10.7 672.5 — — Equity securities 203.9 87.5 17.4 99.0 — Equity and fixed income mutual funds 166.0 27.4 138.6 — — Investments in other private equity funds 401.2 — — — 401.2 Real estate investments 479.4 — — — 479.4 Total assets at fair value $ 8,612.9 $ 125.6 $ 6,956.2 $ 650.5 $ 880.6 As of December 31, 2022 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Investments Measured at NAV as a practical expedient Assets: Bank loans $ 6,315.1 $ — $ 6,069.8 $ 245.3 $ — Bonds 697.5 8.8 688.2 0.5 — Equity securities 274.9 129.9 29.8 115.2 — Equity and fixed income mutual funds 230.7 38.8 191.9 — — Investments in other private equity funds 461.2 — — 7.6 453.6 Real estate investments 552.0 — — — 552.0 Total assets at fair value $ 8,531.4 $ 177.5 $ 6,979.7 $ 368.6 $ 1,005.6 The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs: Three months ended September 30, 2023 2022 (in millions) Level 3 Assets Level 3 Assets Beginning Balance as of July 1 $ 490.8 $ 328.3 Purchases 220.4 2.1 Sales (11.7) (2.7) Deconsolidation of CIP — — Gains and losses included in the Consolidated Statements of Income (9.3) 6.0 Transfers from Level 3 into Levels 1 or 2 (78.9) (130.3) Transfers into Level 3 from Levels 1 or 2 36.0 126.0 Foreign exchange 3.2 (0.6) Ending Balance as of September 30 $ 650.5 $ 328.8 Nine months ended September 30, 2023 2022 (in millions) Level 3 Assets Level 3 Assets Beginning Balance as of January 1 $ 368.6 $ 239.5 Purchases 430.9 2.2 Sales (53.8) (11.3) Deconsolidation of CIP (0.6) — Gains and losses included in the Consolidated Statements of Income (10.6) 3.8 Transfers from Level 3 into Levels 1 or 2 (321.4) (223.8) Transfers into Level 3 from Levels 1 or 2 231.9 319.4 Foreign exchange 5.5 (1.0) Ending Balance as of September 30 $ 650.5 $ 328.8 Non-consolidated Variable interest entities (VIEs) At September 30, 2023, the company's risk of loss with respect to VIEs in which the company is not the primary beneficiary included our investment carrying value of $141.0 million (December 31, 2022: $111.5 million) and unfunded capital commitments of $142.4 million (December 31, 2022: $99.0 million). See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. |
RELATED PARTIES
RELATED PARTIES | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTIES | RELATED PARTIES MassMutual owns approxim ately 18.1% in common stock of the company and owns all of the outstanding $4.0 billion in perpetual, non-cumulative preferred shares as of September 30, 2023. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes representation on Invesco’s Board of Directors, the company considers MassMutual a related party. Additionally, certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” The majority of the company's operating revenues and receivables are from Invesco's managed funds. Related parties also include those defined in the company’s proxy statement. Refer to Note 2, "Fair Value of Assets and Liabilities" and Note 3, "Investments" for more information on balances invested in Invesco affiliated funds. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS On October 24, 2023, the company declared a third quarter 2023 dividend of $0.20 per common share, payable on December 4, 2023, to common shareholders of record at the close of business on November 10, 2023 with an ex-dividend date of November 9, 2023. On October 24, 2023, the company declared a preferred dividend of $14.75 per preferred share to the holders of preferred shares representing the period from September 1, 2023 through November 30, 2023. The preferred dividend is payable on December 1, 2023 to preferred shareholders of record at the close of business on November 15, 2023. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Pay vs Performance Disclosure | ||||
Net income attributable to Invesco Ltd. | $ 131.4 | $ 177.4 | $ 408.6 | $ 496.1 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Sep. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
ACCOUNTING POLICIES (Policies)
ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Accounting and Consolidation | Basis of Accounting and ConsolidationThe unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. |
Accounting Pronouncements Recently Adopted and Pending Accounting Pronouncements | Accounting Pronouncements Recently Adopted None. Pending Accounting Pronouncements None. |
FAIR VALUE OF ASSETS AND LIAB_2
FAIR VALUE OF ASSETS AND LIABILITIES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value by Balance Sheet Grouping | The fair value of financial instruments is presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note 11, "Consolidated Investment Products". See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. September 30, 2023 December 31, 2022 (in millions) Fair Value Fair Value Cash and cash equivalents $ 1,241.5 $ 1,234.7 Equity investments 271.0 325.0 Foreign time deposits (1) — 25.7 Assets held for policyholders 408.4 668.7 Policyholder payables (1) (408.4) (668.7) Total return swaps related to deferred compensation plans (10.1) (1.6) ____________ (1) These financial instruments are not measured at fair value on a recurring basis. Foreign time deposits are measured at cost plus accrued interest, which approximates fair value, and are accordingly classified as Level 2 securities. Policyholder payables are indexed to the value of the assets held for policyholders and changes in fair value are recorded and offset to zero in other operating revenues . |
Tri-Level Hierarchy, Carrying Value | The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022, respectively: As of September 30, 2023 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds (1) $ 711.3 $ 711.3 $ — $ — Investments: (2) Equity investments: Seed capital 90.0 90.0 — — Investments related to deferred compensation plans 179.6 179.6 — — Other equity securities 1.4 1.4 — — Assets held for policyholders (3) 408.4 408.4 — — Total $ 1,390.7 $ 1,390.7 $ — $ — Liabilities: Total return swaps related to deferred compensation plans (10.1) — (10.1) — Contingent consideration liability $ (1.3) $ — $ — $ (1.3) Total $ (11.4) $ — $ (10.1) $ (1.3) As of December 31, 2022 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds (1) $ 760.8 $ 760.8 $ — $ — Investments (2) : Equity investments: Seed capital 177.9 177.9 — — Investments related to deferred compensation plans 146.1 146.1 — — Other equity securities 1.0 1.0 — — Assets held for policyholders (3) 668.7 668.7 — — Total $ 1,754.5 $ 1,754.5 $ — $ — Liabilities: Total return swaps related to deferred compensation plans $ (1.6) $ — $ (1.6) $ — Contingent consideration liability (1.3) — — (1.3) Total $ (2.9) $ — $ (1.6) $ (1.3) ____________ ( 1) The balance primarily represents cash held in affiliated money market funds. (2) Equity method and other investments of $637.0 million and $24.6 million, res pectively, are excluded from this table (December 31, 2022: $621.2 million and $24.7 million, respectively). These investments are not measured at fair value, in accordance with applicable accounting standards. (3) The majority of a ssets held for policyholders are held in affiliated funds. |
INVESTMENTS (Tables)
INVESTMENTS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Investments [Abstract] | |
Marketable Securities | The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 11, "Consolidated Investment Products". (in millions) September 30, 2023 December 31, 2022 Equity investments: Seed capital $ 90.0 $ 177.9 Investments related to deferred compensation plans 179.6 146.1 Other equity securities 1.4 1.0 Equity method investments 637.0 621.2 Foreign time deposits — 25.7 Other 24.6 24.7 Total investments (1) $ 932.6 $ 996.6 ____________ (1) The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees. |
DEBT (Tables)
DEBT (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Long-Term Debt Instruments | The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products". September 30, 2023 December 31, 2022 (in millions) Carrying Value (2) Fair Value Carrying Value (2) Fair Value $2.0 billion floating rate credit facility expiring April 26, 2028 $ — $ — $ — $ — Unsecured Senior Notes: (1) $600 million 4.000% - due January 30, 2024 599.6 596.0 598.8 591.5 $500 million 3.750% - due January 15, 2026 498.4 479.2 497.9 486.4 $400 million 5.375% - due November 30, 2043 391.1 358.9 390.9 397.3 Debt $ 1,489.1 $ 1,434.1 $ 1,487.6 $ 1,475.2 ____________ (1) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures. (2) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts. |
SHARE CAPITAL (Tables)
SHARE CAPITAL (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Movements in Shares Issued and Outstanding | The number of preferred shares issued and outstanding is represented in the table below: As of (in millions) September 30, 2023 December 31, 2022 Preferred shares issued (1) 4.0 4.0 Preferred shares outstanding (1) 4.0 4.0 __________ (1) Preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the preferred shares by MassMutual until May 24, 2024. The number o f common shares and common share equivalents issued are represented in the table below: As of (in millions) September 30, 2023 December 31, 2022 Common shares issued 566.1 566.1 Less: Treasury shares for which dividend and voting rights do not apply (116.5) (111.3) Common shares outstanding 449.6 454.8 |
OTHER COMPREHENSIVE INCOME_(L_2
OTHER COMPREHENSIVE INCOME/(LOSS) (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Income/(Loss) | The components of accumulated other comprehensive income/(loss) were as follows: Three months ended September 30, 2023 Three months ended September 30, 2022 (in millions) Foreign currency translation Employee benefit plans Total Foreign currency translation Employee benefit plans Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries $ (143.0) $ — $ (143.0) $ (330.1) $ — $ (330.1) Other comprehensive income/(loss), net — 0.7 0.7 — 0.2 0.2 Other comprehensive income/(loss), net of tax (143.0) 0.7 (142.3) (330.1) 0.2 (329.9) Beginning balance (696.1) (122.2) (818.3) (712.0) (89.1) (801.1) Other comprehensive income/(loss), net of tax (143.0) 0.7 (142.3) (330.1) 0.2 (329.9) Ending balance $ (839.1) $ (121.5) $ (960.6) $ (1,042.1) $ (88.9) $ (1,131.0) Nine months ended September 30, 2023 Nine months ended September 30, 2022 (in millions) Foreign currency translation Employee benefit plans Total Foreign currency translation Employee benefit plans Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries $ (24.1) $ — $ (24.1) $ (690.2) $ — $ (690.2) Other comprehensive income/(loss), net — 5.9 5.9 — 0.7 0.7 Other comprehensive income/(loss), net of tax (24.1) 5.9 (18.2) (690.2) 0.7 (689.5) Beginning balance (815.0) (127.4) (942.4) (351.9) (89.6) (441.5) Other comprehensive income/(loss), net of tax (24.1) 5.9 (18.2) (690.2) 0.7 (689.5) Ending balance $ (839.1) $ (121.5) $ (960.6) $ (1,042.1) $ (88.9) $ (1,131.0) |
REVENUE (Tables)
REVENUE (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Geographic Disaggregation of Revenue | The geographic disaggregation of revenue for the three and nine months ended September 30, 2023 and 2022 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda. Three months ended September 30, (in millions) 2023 2022 Americas $ 1,107.3 $ 1,125.1 Asia-Pacific (APAC) 64.6 63.2 Europe, Middle East and Africa (EMEA) 270.1 257.4 Total operating revenues $ 1,442.0 $ 1,445.7 Nine months ended September 30, (in millions) 2023 2022 Americas $ 3,298.8 $ 3,553.2 Asia-Pacific (APAC) $ 198.2 $ 218.7 Europe, Middle East and Africa (EMEA) $ 806.0 $ 833.6 Total operating revenues $ 4,303.0 $ 4,605.5 |
COMMON SHARE-BASED COMPENSATI_2
COMMON SHARE-BASED COMPENSATION (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Movements of Share Awards | Movements on employee common share awards during the periods ended September 30 are detailed below: Nine months ended September 30, 2023 Nine months ended September 30, 2022 (in millions of common shares, except fair values) Time- Vested Performance- Vested Weighted Average Grant Date Fair Value Time- Vested Performance- Vested Unvested at the beginning of period 10.3 2.1 $ 19.03 13.5 1.9 Granted during the period 5.2 0.7 17.64 3.6 1.0 Forfeited during the period (0.2) (0.2) 16.49 (0.3) (0.1) Vested and distributed during the period (5.0) (0.5) 18.02 (6.2) (0.4) Unvested at the end of the period 10.3 2.1 $ 18.90 10.6 2.4 |
EARNINGS PER COMMON SHARE (Tabl
EARNINGS PER COMMON SHARE (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Calculation of Earnings Per Share | The calculation of earnings per common share (EPS) is as follows: Three months ended September 30, Nine months ended September 30, (in millions, except per share data) 2023 2022 2023 2022 Net income attributable to Invesco Ltd. $ 131.4 $ 177.4 $ 408.6 $ 496.1 Invesco Ltd: Weighted average common shares outstanding - basic 451.7 457.0 455.9 457.7 Dilutive effect of non-participating common share-based awards 1.4 2.5 1.3 2.3 Weighted average common shares outstanding - diluted 453.1 459.5 457.2 460.0 Earnings per common share: -basic $ 0.29 $ 0.39 $ 0.90 $ 1.08 -diluted $ 0.29 $ 0.39 $ 0.89 $ 1.08 |
CONSOLIDATED INVESTMENT PRODU_2
CONSOLIDATED INVESTMENT PRODUCTS (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Consolidated Investment Products [Abstract] | |
Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products | The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of September 30, 2023 and December 31, 2022: As of September 30, 2023 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Investments Measured at NAV as a practical expedient Assets: Bank loans $ 6,679.2 $ — $ 6,127.7 $ 551.5 $ — Bonds 683.2 10.7 672.5 — — Equity securities 203.9 87.5 17.4 99.0 — Equity and fixed income mutual funds 166.0 27.4 138.6 — — Investments in other private equity funds 401.2 — — — 401.2 Real estate investments 479.4 — — — 479.4 Total assets at fair value $ 8,612.9 $ 125.6 $ 6,956.2 $ 650.5 $ 880.6 As of December 31, 2022 (in millions) Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Investments Measured at NAV as a practical expedient Assets: Bank loans $ 6,315.1 $ — $ 6,069.8 $ 245.3 $ — Bonds 697.5 8.8 688.2 0.5 — Equity securities 274.9 129.9 29.8 115.2 — Equity and fixed income mutual funds 230.7 38.8 191.9 — — Investments in other private equity funds 461.2 — — 7.6 453.6 Real estate investments 552.0 — — — 552.0 Total assets at fair value $ 8,531.4 $ 177.5 $ 6,979.7 $ 368.6 $ 1,005.6 |
Beginning And Ending Fair Value Measurements For Level Three Assets And Liabilities Table Text Block | The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs: Three months ended September 30, 2023 2022 (in millions) Level 3 Assets Level 3 Assets Beginning Balance as of July 1 $ 490.8 $ 328.3 Purchases 220.4 2.1 Sales (11.7) (2.7) Deconsolidation of CIP — — Gains and losses included in the Consolidated Statements of Income (9.3) 6.0 Transfers from Level 3 into Levels 1 or 2 (78.9) (130.3) Transfers into Level 3 from Levels 1 or 2 36.0 126.0 Foreign exchange 3.2 (0.6) Ending Balance as of September 30 $ 650.5 $ 328.8 Nine months ended September 30, 2023 2022 (in millions) Level 3 Assets Level 3 Assets Beginning Balance as of January 1 $ 368.6 $ 239.5 Purchases 430.9 2.2 Sales (53.8) (11.3) Deconsolidation of CIP (0.6) — Gains and losses included in the Consolidated Statements of Income (10.6) 3.8 Transfers from Level 3 into Levels 1 or 2 (321.4) (223.8) Transfers into Level 3 from Levels 1 or 2 231.9 319.4 Foreign exchange 5.5 (1.0) Ending Balance as of September 30 $ 650.5 $ 328.8 |
FAIR VALUE OF ASSETS AND LIAB_3
FAIR VALUE OF ASSETS AND LIABILITIES - Fair Value of Financial Instruments Held by Consolidated Investments (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Cash and cash equivalents | $ 1,241.5 | $ 1,234.7 | $ 1,023.6 |
Foreign time deposits | 0 | 25.7 | |
Assets held for policyholders | 408.4 | ||
Policyholder payables | (408.4) | (668.7) | |
Total return swaps related to deferred compensation plans | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Derivative liability | (10.1) | (1.6) | |
Fair Value | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Cash and cash equivalents | 1,241.5 | 1,234.7 | |
Equity investments | 271 | 325 | |
Foreign time deposits | 0 | 25.7 | |
Assets held for policyholders | 408.4 | 668.7 | |
Policyholder payables | (408.4) | (668.7) | |
Fair Value | Total return swaps related to deferred compensation plans | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Derivative liability | $ (10.1) | $ (1.6) |
FAIR VALUE OF ASSETS AND LIAB_4
FAIR VALUE OF ASSETS AND LIABILITIES - Tri-Level Hierarchy, Carrying Value (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held for policyholders | $ 408.4 | $ 668.7 |
Total | 1,390.7 | 1,754.5 |
Total | (11.4) | (2.9) |
Equity method investments | 637 | 621.2 |
Other investments | 24.6 | 24.7 |
Total return swaps related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total return swaps related to deferred compensation plans | (10.1) | (1.6) |
Contingent consideration liability | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Contingent consideration liability | (1.3) | (1.3) |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 711.3 | 760.8 |
Seed capital | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 90 | 177.9 |
Investments related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 179.6 | 146.1 |
Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 1.4 | 1 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held for policyholders | 408.4 | 668.7 |
Total | 1,390.7 | 1,754.5 |
Total | 0 | 0 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Total return swaps related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total return swaps related to deferred compensation plans | 0 | 0 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent consideration liability | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Contingent consideration liability | 0 | 0 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 711.3 | 760.8 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Seed capital | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 90 | 177.9 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Investments related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 179.6 | 146.1 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 1.4 | 1 |
Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held for policyholders | 0 | 0 |
Total | 0 | 0 |
Total | (10.1) | (1.6) |
Significant Other Observable Inputs (Level 2) | Total return swaps related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total return swaps related to deferred compensation plans | (10.1) | (1.6) |
Significant Other Observable Inputs (Level 2) | Contingent consideration liability | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Contingent consideration liability | 0 | 0 |
Significant Other Observable Inputs (Level 2) | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 0 | 0 |
Significant Other Observable Inputs (Level 2) | Seed capital | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 0 | 0 |
Significant Other Observable Inputs (Level 2) | Investments related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 0 | 0 |
Significant Other Observable Inputs (Level 2) | Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 0 | 0 |
Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held for policyholders | 0 | 0 |
Total | 0 | 0 |
Total | (1.3) | (1.3) |
Significant Unobservable Inputs (Level 3) | Total return swaps related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total return swaps related to deferred compensation plans | 0 | 0 |
Significant Unobservable Inputs (Level 3) | Contingent consideration liability | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Contingent consideration liability | (1.3) | (1.3) |
Significant Unobservable Inputs (Level 3) | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 0 | 0 |
Significant Unobservable Inputs (Level 3) | Seed capital | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 0 | 0 |
Significant Unobservable Inputs (Level 3) | Investments related to deferred compensation plans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | 0 | 0 |
Significant Unobservable Inputs (Level 3) | Other equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Equity investments | $ 0 | $ 0 |
FAIR VALUE OF ASSETS AND LIAB_5
FAIR VALUE OF ASSETS AND LIABILITIES - Narrative (Details) - Total return swaps related to deferred compensation plans - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
Derivative liability | $ 10.1 | $ 10.1 | $ 1.6 | ||
Designated as Hedging Instrument | |||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
Derivative notional amount | 366.2 | 366.2 | 326.6 | ||
Derivative liability | 10.1 | 10.1 | 1.6 | ||
Net collateral paid balance | 11.9 | 11.9 | $ 0 | ||
Market valuation gain (loss) recognized | $ (16.6) | $ 19.8 | $ 3.8 | $ 91.9 |
INVESTMENTS - Details of Compan
INVESTMENTS - Details of Company Investments (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Schedule of Investments [Line Items] | ||
Equity method investments | $ 637 | $ 621.2 |
Foreign time deposits | 0 | 25.7 |
Other | 24.6 | 24.7 |
Total investments | 932.6 | 996.6 |
Seed capital | ||
Schedule of Investments [Line Items] | ||
Equity investments | 90 | 177.9 |
Investments related to deferred compensation plans | ||
Schedule of Investments [Line Items] | ||
Equity investments | 179.6 | 146.1 |
Other equity securities | ||
Schedule of Investments [Line Items] | ||
Equity investments | $ 1.4 | $ 1 |
INVESTMENTS - Narrative (Detail
INVESTMENTS - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Short-term Investments | ||||
Debt Securities, Available-for-sale [Line Items] | ||||
Net gains (loss) | $ (10.8) | $ 14.4 | $ 13.2 | $ 84.1 |
DEBT - Schedule of Long-Term De
DEBT - Schedule of Long-Term Debt Instruments (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024 | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 600 | |
Debt instrument, interest rate, stated percentage | 4% | |
Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026 | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 500 | |
Debt instrument, interest rate, stated percentage | 3.75% | |
Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043 | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 400 | |
Debt instrument, interest rate, stated percentage | 5.375% | |
Carrying Value | ||
Debt Instrument [Line Items] | ||
Long-term debt | $ 1,489.1 | $ 1,487.6 |
Carrying Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 599.6 | 598.8 |
Carrying Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 498.4 | 497.9 |
Carrying Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 391.1 | 390.9 |
Carrying Value | Floating rate credit facility | ||
Debt Instrument [Line Items] | ||
Credit facility capacity | 2,000 | |
Line of credit facility, amount outstanding | 0 | 0 |
Fair Value | ||
Debt Instrument [Line Items] | ||
Long-term debt | 1,434.1 | 1,475.2 |
Fair Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 596 | 591.5 |
Fair Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 479.2 | 486.4 |
Fair Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 358.9 | 397.3 |
Fair Value | Floating rate credit facility | ||
Debt Instrument [Line Items] | ||
Line of credit facility, amount outstanding | $ 0 | $ 0 |
SHARE CAPITAL - Movements In Sh
SHARE CAPITAL - Movements In Shares Issued and Outstanding (Details) - shares shares in Millions | 9 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
Equity [Abstract] | ||
Preferred shares issued (in shares) | 4 | 4 |
Preferred shares outstanding (in shares) | 4 | 4 |
Lock up, term | 5 years | |
Common shares issued | 566.1 | 566.1 |
Less: Treasury shares for which dividend and voting rights do not apply | (116.5) | (111.3) |
Common shares outstanding | 449.6 | 454.8 |
OTHER COMPREHENSIVE INCOME_(L_3
OTHER COMPREHENSIVE INCOME/(LOSS) - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Currency translation differences on investments in foreign subsidiaries | $ (143) | $ (330.1) | $ (24.1) | $ (690.2) |
Other comprehensive income/(loss), net | 0.7 | 0.2 | 5.9 | 0.7 |
Other comprehensive income/(loss) | (142.3) | (329.9) | (18.2) | (689.5) |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | 15,866.7 | 15,794.8 | 15,843.5 | 16,168 |
Other comprehensive income/(loss), net of tax | (142.3) | (329.9) | (18.2) | (689.5) |
Ending balance | 15,837.6 | 15,513.1 | 15,837.6 | 15,513.1 |
Foreign currency translation | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Currency translation differences on investments in foreign subsidiaries | (143) | (330.1) | (24.1) | (690.2) |
Other comprehensive income/(loss), net | 0 | 0 | 0 | 0 |
Other comprehensive income/(loss) | (143) | (330.1) | (24.1) | (690.2) |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | (696.1) | (712) | (815) | (351.9) |
Other comprehensive income/(loss), net of tax | (143) | (330.1) | (24.1) | (690.2) |
Ending balance | (839.1) | (1,042.1) | (839.1) | (1,042.1) |
Employee benefit plans | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Currency translation differences on investments in foreign subsidiaries | 0 | 0 | 0 | 0 |
Other comprehensive income/(loss), net | 0.7 | 0.2 | 5.9 | 0.7 |
Other comprehensive income/(loss) | 0.7 | 0.2 | 5.9 | 0.7 |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | (122.2) | (89.1) | (127.4) | (89.6) |
Other comprehensive income/(loss), net of tax | 0.7 | 0.2 | 5.9 | 0.7 |
Ending balance | (121.5) | (88.9) | (121.5) | (88.9) |
Total | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Other comprehensive income/(loss) | (142.3) | (329.9) | (18.2) | (689.5) |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | (818.3) | (801.1) | (942.4) | (441.5) |
Other comprehensive income/(loss), net of tax | (142.3) | (329.9) | (18.2) | (689.5) |
Ending balance | $ (960.6) | $ (1,131) | $ (960.6) | $ (1,131) |
REVENUE - Disaggregation of Rev
REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenue, Major Customer [Line Items] | ||||
Total operating revenues | $ 1,442 | $ 1,445.7 | $ 4,303 | $ 4,605.5 |
Bermuda | ||||
Revenue, Major Customer [Line Items] | ||||
Total operating revenues | 0 | 0 | ||
Americas | ||||
Revenue, Major Customer [Line Items] | ||||
Total operating revenues | 1,107.3 | 1,125.1 | 3,298.8 | 3,553.2 |
Asia-Pacific (APAC) | ||||
Revenue, Major Customer [Line Items] | ||||
Total operating revenues | 64.6 | 63.2 | 198.2 | 218.7 |
Europe, Middle East and Africa (EMEA) | ||||
Revenue, Major Customer [Line Items] | ||||
Total operating revenues | $ 270.1 | $ 257.4 | $ 806 | $ 833.6 |
COMMON SHARE-BASED COMPENSATI_3
COMMON SHARE-BASED COMPENSATION - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | ||
Common share-based compensation expense | $ 93.7 | $ 83.1 |
Fair value of vested shares | $ 96.3 | $ 131.7 |
Weighted average fair value of shares granted (in USD per share) | $ 17.64 | $ 21.23 |
Unrecognized compensation cost related to non-vested shares | $ 143.4 | |
Weighted average non-vested shares compensation cost expected to recognize | 2 years 6 months 18 days |
COMMON SHARE-BASED COMPENSATI_4
COMMON SHARE-BASED COMPENSATION - Movements on Share Awards (Details) - $ / shares shares in Millions | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Weighted Average Grant Date Fair Value | ||
Unvested at the beginning of period (in USD per share) | $ 19.03 | |
Granted during the period (in USD per share) | 17.64 | $ 21.23 |
Forfeited during the period (in USD per share) | 16.49 | |
Vested and distributed during the period (in USD per share) | 18.02 | |
Unvested at the end of the period (in USD per share) | $ 18.90 | |
Time- Vested | ||
Number of Shares | ||
Unvested at the beginning of period (in shares) | 10.3 | 13.5 |
Granted during the period (in shares) | 5.2 | 3.6 |
Forfeited during the period (in shares) | (0.2) | (0.3) |
Vested and distributed during the period (in shares) | (5) | (6.2) |
Unvested at the end of the period (in shares) | 10.3 | 10.6 |
Performance- Vested | ||
Number of Shares | ||
Unvested at the beginning of period (in shares) | 2.1 | 1.9 |
Granted during the period (in shares) | 0.7 | 1 |
Forfeited during the period (in shares) | (0.2) | (0.1) |
Vested and distributed during the period (in shares) | (0.5) | (0.4) |
Unvested at the end of the period (in shares) | 2.1 | 2.4 |
EARNINGS PER COMMON SHARE (Deta
EARNINGS PER COMMON SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Earnings Per Share [Abstract] | ||||
Net income attributable to Invesco Ltd. | $ 131.4 | $ 177.4 | $ 408.6 | $ 496.1 |
Weighted average common shares outstanding - basic (shares) | 451.7 | 457 | 455.9 | 457.7 |
Dilutive effect of non-participating common share-based awards (shares) | 1.4 | 2.5 | 1.3 | 2.3 |
Weighted average common shares outstanding - diluted (shares) | 453.1 | 459.5 | 457.2 | 460 |
Earnings per common share: | ||||
Basic (in USD per share) | $ 0.29 | $ 0.39 | $ 0.90 | $ 1.08 |
Diluted (in USD per share) | $ 0.29 | $ 0.39 | $ 0.89 | $ 1.08 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Millions | 9 Months Ended | 12 Months Ended |
Sep. 30, 2023 | Dec. 31, 2022 | |
Loss Contingencies [Line Items] | ||
Undrawn capital commitments | $ 659 | $ 336.1 |
Equity Commitment | ||
Loss Contingencies [Line Items] | ||
Maximum guarantee | 30 | |
Equity Commitment | Maximum | ||
Loss Contingencies [Line Items] | ||
Commitments | $ 274 |
CONSOLIDATED INVESTMENT PRODU_3
CONSOLIDATED INVESTMENT PRODUCTS - Narrative (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Variable Interest Entity [Line Items] | ||
Net interests in consolidated investment products | $ 543.6 | $ 386.6 |
Variable interest entity, unfunded capital commitments | 142.4 | 99 |
De-consolidated | ||
Variable Interest Entity [Line Items] | ||
Carrying value and maximum risk of loss with respect to VIEs in which the Company is not primary beneficiary | $ 141 | $ 111.5 |
CONSOLIDATED INVESTMENT PRODU_4
CONSOLIDATED INVESTMENT PRODUCTS - Fair Value Hierarchy Levels of Investments Held and Notes Issued by Consolidated Investment Products (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Total assets at fair value | $ 8,612.9 | $ 8,531.4 |
Consolidated | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Real estate investments | 479.4 | 552 |
Total assets at fair value | 8,612.9 | 8,531.4 |
Consolidated | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Real estate investments | 0 | 0 |
Total assets at fair value | 125.6 | 177.5 |
Consolidated | Significant Other Observable Inputs (Level 2) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Real estate investments | 0 | 0 |
Total assets at fair value | 6,956.2 | 6,979.7 |
Consolidated | Significant Unobservable Inputs (Level 3) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Real estate investments | 0 | 0 |
Total assets at fair value | 650.5 | 368.6 |
Consolidated | Investments Measured at NAV as a practical expedient | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Real estate investments | 479.4 | 552 |
Total assets at fair value | 880.6 | 1,005.6 |
Consolidated | Bank loans | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 6,679.2 | 6,315.1 |
Consolidated | Bank loans | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 0 | 0 |
Consolidated | Bank loans | Significant Other Observable Inputs (Level 2) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 6,127.7 | 6,069.8 |
Consolidated | Bank loans | Significant Unobservable Inputs (Level 3) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 551.5 | 245.3 |
Consolidated | Bank loans | Investments Measured at NAV as a practical expedient | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 0 | 0 |
Consolidated | Bonds | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 683.2 | 697.5 |
Consolidated | Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 10.7 | 8.8 |
Consolidated | Bonds | Significant Other Observable Inputs (Level 2) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 672.5 | 688.2 |
Consolidated | Bonds | Significant Unobservable Inputs (Level 3) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 0 | 0.5 |
Consolidated | Bonds | Investments Measured at NAV as a practical expedient | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 0 | 0 |
Consolidated | Equity securities, Equity and fixed income mutual funds | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 203.9 | 274.9 |
Equity and fixed income mutual funds, and investments in other private equity funds | 166 | 230.7 |
Consolidated | Equity securities, Equity and fixed income mutual funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 87.5 | 129.9 |
Equity and fixed income mutual funds, and investments in other private equity funds | 27.4 | 38.8 |
Consolidated | Equity securities, Equity and fixed income mutual funds | Significant Other Observable Inputs (Level 2) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 17.4 | 29.8 |
Equity and fixed income mutual funds, and investments in other private equity funds | 138.6 | 191.9 |
Consolidated | Equity securities, Equity and fixed income mutual funds | Significant Unobservable Inputs (Level 3) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 99 | 115.2 |
Equity and fixed income mutual funds, and investments in other private equity funds | 0 | 0 |
Consolidated | Equity securities, Equity and fixed income mutual funds | Investments Measured at NAV as a practical expedient | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Bank loan, bonds and equity securities | 0 | 0 |
Equity and fixed income mutual funds, and investments in other private equity funds | 0 | 0 |
Consolidated | Investments in other private equity funds | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Equity and fixed income mutual funds, and investments in other private equity funds | 401.2 | 461.2 |
Consolidated | Investments in other private equity funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Equity and fixed income mutual funds, and investments in other private equity funds | 0 | 0 |
Consolidated | Investments in other private equity funds | Significant Other Observable Inputs (Level 2) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Equity and fixed income mutual funds, and investments in other private equity funds | 0 | 0 |
Consolidated | Investments in other private equity funds | Significant Unobservable Inputs (Level 3) | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Equity and fixed income mutual funds, and investments in other private equity funds | 0 | 7.6 |
Consolidated | Investments in other private equity funds | Investments Measured at NAV as a practical expedient | ||
Segment Reporting, Other Significant Reconciling Items [Line Items] | ||
Equity and fixed income mutual funds, and investments in other private equity funds | $ 401.2 | $ 453.6 |
CONSOLIDATED INVESTMENT PRODU_5
CONSOLIDATED INVESTMENT PRODUCTS - Beginning and Ending Fair Value Measurements for Level 3 Assets and Liabilities (Details) - Significant Unobservable Inputs (Level 3) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Beginning Balance as of July 1 | $ 490.8 | $ 328.3 | $ 368.6 | $ 239.5 |
Purchases | 220.4 | 2.1 | 430.9 | 2.2 |
Sales | (11.7) | (2.7) | (53.8) | (11.3) |
Deconsolidation of CIP | 0 | 0 | (0.6) | 0 |
Gains and losses included in the Consolidated Statements of Income | (9.3) | 6 | (10.6) | 3.8 |
Transfers from Level 3 into Levels 1 or 2 | (78.9) | (130.3) | (321.4) | (223.8) |
Transfers into Level 3 from Levels 1 or 2 | 36 | 126 | 231.9 | 319.4 |
Foreign exchange | 3.2 | (0.6) | 5.5 | (1) |
Ending Balance as of September 30 | $ 650.5 | $ 328.8 | $ 650.5 | $ 328.8 |
RELATED PARTIES (Details)
RELATED PARTIES (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
Related Party Transactions [Line Items] | ||
Stock consideration | $ 4,010.5 | $ 4,010.5 |
MassMutual | Invesco | MassMutual | ||
Related Party Transactions [Line Items] | ||
Approximate stake help in common stock of combined firm (percent) | 18.10% |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - $ / shares | 3 Months Ended | 9 Months Ended | |||
Oct. 24, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Subsequent Event [Line Items] | |||||
Common stock dividends declared per share (in USD per share) | $ 0.20 | $ 0.1875 | $ 0.5875 | $ 0.5450 | |
Preferred stock dividend declared (in USD per share) | $ 14.75 | $ 14.75 | $ 44.25 | $ 44.25 | |
Subsequent Event | |||||
Subsequent Event [Line Items] | |||||
Common stock dividends declared per share (in USD per share) | $ 0.20 | ||||
Preferred stock dividend declared (in USD per share) | $ 14.75 |